• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Intron A (Interferon alfa-2b, recombinant)

Detailed View: Safety Labeling Changes Approved By FDA Center for Biologics Evaluation and Research (CBER) – June 2012


Summary View



  • Updated in order to make it consistent with the Boxed Warning and Neuropsychiatric Disorders subsection under Warning section of the Package Insert.